Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from healthy controls and early stage CRC patient's tumor


ABSTRACT: Metastasis is the major cause of cancer mortality. Up to 25% of early stage sporadic colorectal cancer (CRC) patients succumb to metastasis after curative surgery. We used microarrays to detail gene expression and identified a metastasis-prone signature for early stage CRC. Keywords: RNA expression Tumors from age- and ethnicity-matched 70 patients and biopsies from 12 healthy controls were used. We aimed to find a metastasis-prone signature for early stage CRC by genome-wide expression profiling of age- and ethnicity-matched patients and healthy controls using the Affymetrix U133 Plus 2 array.

ORGANISM(S): Homo sapiens

SUBMITTER: Yi Hong 

PROVIDER: E-GEOD-9348 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics.

Hong Yi Y   Downey Thomas T   Eu Kong Weng KW   Koh Poh Koon PK   Cheah Peh Yean PY  

Clinical & experimental metastasis 20100209 2


Metastasis is the major cause of cancer mortality. We aimed to find a metastasis-prone signature for early stage mismatch-repair proficient sporadic colorectal cancer (CRC) patients for better prognosis and informed use of adjuvant chemotherapy. The genome-wide expression profiles of 82 age-, ethnicity- and tissue-matched patients and healthy controls were analyzed using the Affymetrix U133 Plus 2 array. Metastasis-negative patients have 5 years or more of follow-up. A 10 x 10 two-level nested c  ...[more]

Similar Datasets

2010-02-15 | GSE9348 | GEO
2017-12-19 | GSE100276 | GEO
2023-03-11 | PXD038871 | Pride
2010-02-04 | GSE18105 | GEO
2020-10-05 | GSE148918 | GEO
2011-03-22 | E-GEOD-22834 | biostudies-arrayexpress
2017-05-02 | GSE98406 | GEO
2013-01-29 | E-GEOD-26232 | biostudies-arrayexpress
| PRJNA323568 | ENA
| PRJNA323569 | ENA